How will the emergence of lecanemab change dementia treatment? — The introduction of lecanemab has dramatically changed the field of dementia medicine. Lecanemab, defined as an anti-amyloid-β (Aβ) drug, comprises an antibody against Aβ, a protein structure believed to cause Alzheimer's disease. This drug represents...

Evidence span

How will the emergence of lecanemab change dementia treatment? — The introduction of lecanemab has dramatically changed the field of dementia medicine. Lecanemab, defined as an anti-amyloid-β (Aβ) drug, comprises an antibody against Aβ, a protein structure believed to cause Alzheimer's disease. This drug represents...

From Iwata A 2024, Geriatrics & gerontology international

Method & conditions

Evidence type

experimental

Method

manual state transition; control details require source inspection

Species

Homo sapiens

Conditions

Humans; Dementia; Alzheimer Disease; Quality of Life; Aged — Geriatrics & gerontology international 2024

Replicated

not yet

Confidence basis

operator-supplied frontier prior; review required